Harvard, MIT research team holds on to gene-editing patent rights

(Reuters) - A team of researchers affiliated with the Massachusetts Institute of Technology and Harvard University will keep valuable patents on a revolutionary gene-editing technology known as CRISPR, a U.S. patent agency has ruled.